Apparatus and methods for sealing a vascular puncture
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61B-017/00
A61B-017/03
A61L-024/02
B29C-070/76
A61L-024/00
A61L-024/04
A61B-017/22
A61B-090/90
출원번호
US-0276989
(2014-05-13)
등록번호
US-9820728
(2017-11-21)
발명자
/ 주소
Mylonakis, Andreas
Au-Yeung, Jacky
Lim, Florencia
출원인 / 주소
Access Closure, Inc.
대리인 / 주소
Maharaj, Amanda F.
인용정보
피인용 횟수 :
1인용 특허 :
143
초록▼
A sealant for sealing a puncture through tissue includes a first section, e.g., formed from freeze-dried hydrogel, and a second section extending from the distal end. The second section may be formed from PEG-precursors including PEG-ester and PEG-amine, e.g., in an equivalent ratio of active group
A sealant for sealing a puncture through tissue includes a first section, e.g., formed from freeze-dried hydrogel, and a second section extending from the distal end. The second section may be formed from PEG-precursors including PEG-ester and PEG-amine, e.g., in an equivalent ratio of active group sites of PEG-ester/PEG-amine greater than one-to-one, e.g., such that excess esters may provide faster activation upon contact with physiological fluids and enhance adhesion of the sealant within a puncture. At least some of the precursors remain in an unreactive state until exposed to an aqueous physiological environment, e.g., within a puncture, whereupon the precursors undergo in-situ cross-linking to provide adhesion to tissue adjacent the puncture. For example, the PEG-amine precursors may include the free amine form and the salt form. The free amine form at least partially cross-links with the PEG-ester and the salt form remains in the unreactive state in the sealant before introduction into the puncture.
대표청구항▼
1. A sealant for sealing a puncture through tissue, comprising: an elongate first section including a proximal end, a distal end, and a cross-section sized for delivery into a puncture through tissue, wherein the first section is formed from a freeze-dried hydrogel that expands when exposed to physi
1. A sealant for sealing a puncture through tissue, comprising: an elongate first section including a proximal end, a distal end, and a cross-section sized for delivery into a puncture through tissue, wherein the first section is formed from a freeze-dried hydrogel that expands when exposed to physiological fluid within the puncture; anda second section extending from the distal end of the first section, the second section comprising PEG-precursors comprising PEG-ester and PEG-amine precursors in a ratio of active group sites of PEG-ester/PEG-amine of greater than one-to-one (1:1), at least some of the precursors remaining in an unreactive state until exposed to an aqueous physiological environment, whereupon the precursors undergo in-situ cross-linking with one another to provide adhesion to tissue adjacent the puncture. 2. The sealant of claim 1, wherein the ratio of active group sites of PEG-ester/PEG-amine is between about 65/35 and 55/45. 3. The sealant of claim 1, wherein the ratio of active group sites of PEG-ester/PEG-amine is about 60/40. 4. The sealant of claim 1, wherein the PEG-amine precursors of the second section comprise both a free amine form of PEG-amine precursors and a salt form of PEG-amine precursors. 5. The sealant of claim 4, wherein a ratio of active group sites of PEG-ester precursors/salt form of PEG-amine precursors/free amine form of PEG-amine precursors is between about 50/42/8 and 50/48/2. 6. The sealant of claim 4, wherein a ratio of active group sites of PEG-ester precursors/salt form of PEG-amine precursors/free amine form of PEG-amine precursors is between about 60/32/8 and 60/38/2. 7. The sealant of claim 4, wherein a ratio of active group sites of PEG-ester precursors/salt form of PEG-amine precursors/free amine form of PEG-amine precursors is between about 50/45/5 and 70/25/5. 8. The sealant of claim 4, wherein a ratio of active group sites of PEG-ester precursors/salt form of PEG-amine precursors/free amine form of PEG-amine precursors is about 60/35/5. 9. The sealant of claim 4, wherein the free amine form of PEG-amine precursors are at least partially cross-linked with the PEG-ester precursors, and the salt form of PEG-amine precursors remain in the unreactive state until exposed to an aqueous physiological environment, whereupon the salt form of PEG-amine precursors undergo in-situ cross-linking with the PEG-ester precursors to provide adhesion to tissue adjacent the puncture. 10. The sealant of claim 1, wherein the precursors of the second section permeate into the distal end of the first section to create a transition zone between the first and second sections. 11. The sealant of claim 1, wherein the second section comprises a solid mass of non-cross-linked precursors. 12. The sealant of claim 11, wherein the solid mass comprises a substantially uniform solid plug of the non-cross-linked precursors. 13. The sealant of claim 1, wherein the first section comprises a sheet rolled into a tubular shape, thereby defining a lumen extending between the proximal and distal ends, and wherein the second section comprises a passage there through aligned with the lumen. 14. The sealant of claim 1, wherein the first section has a length between the proximal and distal ends between about one and twenty millimeters (1-20 mm), and the second section has a length extending from the distal end that is substantially shorter than the length of the first section. 15. The sealant of claim 1, wherein the first and second sections have a substantially uniform outer cross-section along their lengths between about one and eight millimeters (1-8 mm). 16. A sealant for sealing a puncture through tissue, comprising: an elongate first section including a proximal end, a distal end, and a cross-section sized for delivery into a puncture through tissue, the first section formed from a freeze-dried hydrogel that expands when exposed to physiological fluid within a puncture; anda second section extending from the distal end of the first section, the second section comprising PEG-precursors comprising PEG-ester and PEG-amine precursors in a ratio of active group sites of PEG-ester/PEG-amine of greater than one-to-one (1:1), the PEG-amine precursors including both a free amine form of PEG-amine precursors that are at least partially cross-linked with the PEG-ester precursors and a salt form of PEG-amine precursors that remain in an unreactive state until exposed to an aqueous physiological environment, whereupon the salt form of PEG-amine precursors undergo in-situ cross-linking with the PEG-ester precursors to provide adhesion to tissue adjacent the puncture. 17. A method for making a sealant for sealing a puncture through tissue, comprising: forming an elongate first section including a proximal end, a distal end, and a cross-section sized for delivery into a puncture through tissue, wherein the first section is formed from a freeze-dried hydrogel that expands when exposed to physiological fluid within a puncture;melting PEG-amine and PEG-ester powders into a liquid mixture comprising non-cross-linked PEG precursors, wherein a ratio of active group sites of the PEG-ester precursors to the PEG-amine precursors is greater than one-to-one (1:1); and fusing a solid mass of the mixed PEG precursors onto the distal end, at least some of the PEG precursors remaining in an unreactive state until exposed to an aqueous physiological, whereupon the precursors undergo in-situ cross-linking with one another to provide an adhesive layer bonded to the first section. 18. An apparatus for sealing a puncture extending through tissue, comprising: a tubular member comprising a proximal end, a distal end sized for insertion into a puncture, a lumen extending between the proximal and distal ends, and a distal opening in communication with the lumen; anda sealant comprising an elongate first section including proximal and distal ends, wherein the first section is formed from a freeze-dried hydrogel that expands when exposed to physiological fluid within a puncture, and a second section fused to and extending from the distal end, the sealant disposed within the lumen such that the second section is disposed closer to the distal opening than the first section, the second section comprising PEG-precursors comprising PEG-ester and PEG-amine precursors in a ratio of active group sites of PEG-ester/PEG-amine of greater than one-to-one (1:1), at least some of the precursors remaining in an unreactive state until exposed to an aqueous physiological environment, whereupon the precursors undergo in-situ cross-linking with one another to provide adhesion to tissue adjacent the puncture. 19. A method for sealing a puncture extending through tissue of a patient, comprising: providing a sealant comprising a first section including proximal and distal ends, wherein the first section is formed from a freeze-dried hydrogel that expands when exposed to physiological fluid within a puncture, and a second section extending from the distal end, the second section comprising PEG-precursors comprising PEG-ester and PEG-amine precursors in a ratio of active group sites of PEG-ester/PEG-amine of greater than one-to-one (1:1), at least some of the PEG precursors in an unreactive state;introducing the sealant into a puncture through tissue with the second section entering the puncture before the first section; andexposing the sealant to fluid within the puncture, whereupon the at least some of the PEG precursors of the second section undergo in-situ cross-linking with one another to provide adhesion to tissue adjacent the puncture. 20. A sealant for sealing a puncture through tissue, comprising: an elongate plug shaped body comprising a fluid-absorbing, biodegradable matrix material and a set of PEG-precursors, the PEG-precursors comprising PEG-ester and PEG-amine precursors in a ratio of active group sites of PEG-ester/PEG-amine of greater than one-to-one (1:1), wherein the elongate plug-shaped body comprises a first section and second section distal to the first section, and the PEG-precursors form at least a portion of the second section, and the first section is formed from a freeze-dried hydrogel that expands when exposed to physiological fluid within a puncture, and wherein at least some of the precursors remaining in an unreactive state until exposed to an aqueous physiological environment, whereupon the precursors undergo in-situ cross-linking with one another to provide adhesion to tissue adjacent the puncture. 21. The sealant of claim 20, wherein the ratio of active group sites of PEG-ester/PEG-amine ranges from 65/35 to 55/45.
Yeung Jeffrey E. (San Jose CA) Chu George H. (Cupertino CA) DeLustro Frank A. (Belmont CA) Rhee Woonza M. (Palo Alto CA), Anti-adhesion films and compositions for medical use.
Hanson Bruce L. (Wayne NJ) Wolvek Sidney (Brooklyn NY), Apparatus and method for the percutaneous introduction of intra-aortic balloons into the human body.
Polson Alan M. (Fort Collins CO) Swanbom Deryl D. (Fort Collins CO) Dunn Richard L. (Fort Collins CO) Cox Charles P. (Fort Collins CO) Norton Richard L. (Fort Collins CO) Lowe Bryan K. (Fort Collins , Apparatus for forming a biodegradable implant precursor.
Epstein Gordon H. ; Lempert Todd E. ; Martin Brian B., Biological sealant mixture and system for use in percutaneous occlusion of puncture sites and tracts in the human body and method.
Epstein Gordon H. ; Taylor David M. ; Corso ; Jr. Philip P., Device for introducing and polymerizing polymeric biomaterials in the human body and method.
Edwards Stuart D. ; Wehman Thomas ; Parker Theodore L. ; Skalnyi Eugene V. ; Kucklick Theodore ; Evans John, Devices for sealing punctures in body vessels.
Chu George H. ; Yeung Jeff E. ; Schroeder Jacqueline Anne ; Shenoy Vivek N. ; Brown Melissa K. C. ; Cassidy James J. ; Rice John, Devices for tissue repair and methods for preparation and use thereof.
McAnalley Bill H. (Grand Prairie TX) Boyd Stephen (Tyler TX) Carpenter Robert H. (Bastrop TX) Hall John E. (Grand Prairie TX) St. John Judith (Irving TX), Dried hydrogel from hydrophilic-hygroscopic polymer.
Epstein Gordon H. ; Lempert Todd E. ; Martin Brian B., Expansile device for use in blood vessels and tracts in the body and tension application device for use therewith and me.
Epstein Gordon H. ; Lempert Todd E. ; Martin Brian B. ; Taylor David M., Expansile device for use in blood vessels and tracts in the body and tension application device for use therewith and me.
Epstein Gordon H. ; Lempert Todd E. ; Martin Brian B. ; Taylor David M., Expansile device for use in blood vessels and tracts in the body and tension application device for use therewith and method.
Makower Joshua (Nanuet NY) Vidal Claude A. (Santa Barbara CA) LeMott Steven R. (East Lyme CT) Wells Rodney E. (East Lyme CT) Banks Thomas F. (Santa Barbara CA), Hemostatic implant introducer.
Makower Joshua (Nanuet NY) Vidal Claude A. (Santa Barbara CA) LeMott Steven R. (East Lyme CT) Wells Rodney E. (East Lyme CT) Banks Thomas F. (Santa Barbara CA), Hemostatic implant introducer.
Park Kinam ; Chen Jun ; Park Haesun, Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties.
Omidian, Hossein; Qiu, Yong; Yang, Shicheng; Kim, Dukjoon; Park, Haesun; Park, Kinam, Hydrogels having enhanced elasticity and mechanical strength properties.
Rhee Woonza M. ; Berg Richard A. ; Chu George H. ; DeLustro Frank A. ; Jolivette Dan M. ; McCullough Kimberly A., Injectable or implantable biomaterials for filling or blocking lumens and voids of the body.
Wolf Stephen J. (Hillsborough NJ) Mart Robert K. (Martinsville NJ) Otto Scott C. (Yardley PA), Locking holder for a pair of syringes and method of use.
Deem Mark E. (Pembroke Pines FL) Slater Andrea T. (Pembroke Pines FL), Medical instrument valve with foam partition member having vapor permeable skin.
Myers Gene (2727 S. Tamiami Trail ; Suite 2A Sarasota FL 34239) Coury William S. (2830 Bay Shore Cir. Sarasota FL 34234), Method and apparatus for arteriotomy closure.
Rhee Woonza M. (Palo Alto CA) Berg Richard A. (Los Altos CA) Rosenblatt Joel S. (Palo Alto CA) Tefft Jacqueline A. (Redwood City CA) Braga Larry J. (Fremont CA) Smestad Thomas L. (Palo Alto CA), Method of preparing crosslinked biomaterial compositions for use in tissue augmentation.
Muijs Van de Moer Wouter Matthijs,NLX ; Rienks Rienk,NLX, Occlusion assembly for sealing openings in blood vessels and a method for sealing openings in blood vessels.
Bagaoisan,Celso J.; Domingo,Juan; Domingo,Nicanor; Khosravi,Farhad; Pai,Suresh S., Occlusion member and tensioner apparatus and methods of their use for sealing a vascular puncture.
Lombardi ; Jr. Edward J. (Malden MA) Neuman Harold L. (Reading MA) Magro Alfred E. (Woburn MA) Rishton Michael L. (Reading MA), Percutaneous intra-aortic balloon apparatus.
Rhee Woonza M. (Palo Alto CA) Berg Richard A. (Los Altos CA) Rosenblatt Joel S. (Palo Alto CA) Schroeder Jacqueline A. (Redwood City CA) Braga Larry J. (Fremont CA) Smestad Thomas L. (Palo Alto CA) F, Process for preparing a sterile, dry crosslinking agent.
Sawhney, Amarpreet S.; Bennett, Steven L.; Pai, Suresh S.; Sershen, Scott R.; Co, Fred H., Superabsorbent, freeze dried hydrogels for medical applications.
Barta Helmut (Vienna ATX) Eder Helmut (Vienna ATX) Granser Manfred (Vienna ATX) Habison Georg (Vienna ATX) Hantak Edith (Seebarn ATX) Moser Franz (Deutsch Wagram ATX) Pfaffenbichler Peter (Podersdorf, Syringe assembly for the storage and application of a biological multi-component material.
Redmond, Russell J.; Vidal, Claude; Reich, Cary J.; Vega, Felix; Collinson, Michael; Rondinone, Joseph F., System and method for sealing vascular penetrations with hemostatic gels.
Magro Alfred E. (Woburn MA) Rishton Michael (Reading MA), Tapered hemostatic device for use in conjunction with a catheter for alleviating blood leakage and method for using same.
Gershony Gary (44332 S. El Macero Dr. El Macero CA 95618) Kasprzyk Daniel J. (Fogelsville PA) Horzewski Michael J. (San Jose CA), Vascular sealing apparatus and method.
Clark Jeffrey G. (Raleigh NC) Spranger Douglas M. (New York NY) Mulhauser Paul J. (New York NY) Lacotta Paul R. (Oradell NJ), Wound closure means and method using flowable adhesive.
Weldon Thomas D. (Gainesville GA) Larsen Charles E. (Cumming GA) Rosen Jonathan J. (Alpharetta GA), Wound treating device and method for treating wounds.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.